KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Cash & Equivalents (2016 - 2026)

Lam Research has reported Cash & Equivalents over the past 18 years, most recently at $4.8 billion for Q1 2026.

  • Quarterly Cash & Equivalents fell 12.84% to $4.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.8 billion through Mar 2026, down 12.84% year-over-year, with the annual reading at $6.4 billion for FY2025, 9.28% up from the prior year.
  • Cash & Equivalents was $4.8 billion for Q1 2026 at Lam Research, down from $6.2 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $6.7 billion in Q3 2025 and troughed at $3.5 billion in Q2 2022.
  • The 5-year median for Cash & Equivalents is $5.5 billion (2025), against an average of $5.3 billion.
  • Biggest five-year swings in Cash & Equivalents: dropped 20.29% in 2022 and later skyrocketed 51.53% in 2023.
  • Tracing LRCX's Cash & Equivalents over 5 years: stood at $4.5 billion in 2022, then grew by 25.39% to $5.6 billion in 2023, then rose by 0.75% to $5.7 billion in 2024, then grew by 9.09% to $6.2 billion in 2025, then decreased by 23.13% to $4.8 billion in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $4.8 billion, $6.2 billion, and $6.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.